SOCIETE DE SYSTEMES BIOLOGIQUES : revenue, balance sheet and financial ratios

SOCIETE DE SYSTEMES BIOLOGIQUES is a French company founded 45 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in APPRIEU (38140), this company of category PME shows in 2022 a revenue of 4.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOCIETE DE SYSTEMES BIOLOGIQUES (SIREN 320508047)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 4 062 647 € N/C 3 137 021 € 2 648 327 € 2 523 305 € 2 722 184 € 2 418 656 €
Net income -184 658 € 106 454 € 233 726 € 350 907 € 397 205 € 104 388 € 99 725 € 312 800 € 203 094 €
EBITDA N/C N/C -80 219 € N/C 254 656 € 234 065 € 104 622 € 242 562 € 147 245 €
Net margin N/C N/C 5.8% N/C 12.7% 3.9% 4.0% 11.5% 8.4%

Revenue and income statement

In 2024, SOCIETE DE SYSTEMES BIOLOGIQUES records a net loss of 185 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-184 658 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 25%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

24.827%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.949%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

41.7%

Solvency indicators evolution
SOCIETE DE SYSTEMES BIOLOGIQUES

Sector positioning

Debt ratio
24.83 2024
2022
2023
2024
Q1: 0.0
Med: 5.92
Q3: 43.75
Average

In 2024, the debt ratio of SOCIETE DE SYSTEMES BIOLO... (24.83) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
66.95% 2024
2022
2023
2024
Q1: 28.05%
Med: 51.52%
Q3: 72.2%
Good

In 2024, the financial autonomy of SOCIETE DE SYSTEMES BIOLO... (67.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
1.89 years 2022
2022
Q1: 0.0 years
Med: 0.0 years
Q3: 1.4 years
Watch

In 2022, the repayment capacity of SOCIETE DE SYSTEMES BIOLO... (1.89) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 324.43. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

324.43

Liquidity indicators evolution
SOCIETE DE SYSTEMES BIOLOGIQUES

Sector positioning

Liquidity ratio
324.43 2024
2022
2023
2024
Q1: 120.09
Med: 209.86
Q3: 363.93
Good

In 2024, the liquidity ratio of SOCIETE DE SYSTEMES BIOLO... (324.43) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-10.67x 2022
2022
Q1: -0.06x
Med: 0.9x
Q3: 6.69x
Watch

In 2022, the interest coverage of SOCIETE DE SYSTEMES BIOLO... (-10.7x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SOCIETE DE SYSTEMES BIOLOGIQUES

Positioning of SOCIETE DE SYSTEMES BIOLOGIQUES in its sector

Comparison with sector Fabrication de préparations pharmaceutiques

Similar companies (Fabrication de préparations pharmaceutiques)

Compare SOCIETE DE SYSTEMES BIOLOGIQUES with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques

Frequently asked questions about SOCIETE DE SYSTEMES BIOLOGIQUES

What is the revenue of SOCIETE DE SYSTEMES BIOLOGIQUES ?

The revenue of SOCIETE DE SYSTEMES BIOLOGIQUES in 2022 is 4.1 M€.

Is SOCIETE DE SYSTEMES BIOLOGIQUES profitable?

SOCIETE DE SYSTEMES BIOLOGIQUES recorded a net loss in 2024.

Where is the headquarters of SOCIETE DE SYSTEMES BIOLOGIQUES ?

The headquarters of SOCIETE DE SYSTEMES BIOLOGIQUES is located in APPRIEU (38140), in the department Isere.

Where to find the tax return of SOCIETE DE SYSTEMES BIOLOGIQUES ?

The tax return of SOCIETE DE SYSTEMES BIOLOGIQUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE DE SYSTEMES BIOLOGIQUES operate?

SOCIETE DE SYSTEMES BIOLOGIQUES operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.